In recent years, we’ve encountered numerous studies warning us about the uncertain future of work, with attention-grabbing headlines like “85 percent of jobs that will exist in 2030 haven’t been invented yet,” as highlighted in the 2017 report from Dell and the Institute for the Future. However, until the public launch of ChatGPT in late 2022, many of us remained blissfully unaware of the imminent impact of generative A.I. As a result, these reports failed to instill a sense of urgency in us. But now, things have changed.

The transformation of the job landscape into something markedly different in just a few short years no longer seems like an exaggeration, especially with IBM’s recent announcement to replace nearly 8,000 jobs with A.I. over the next few years. This development has led everyone, from chief people officers at Fortune 500 companies grappling with unexpected headcount shifts to college students questioning the relevance of their chosen majors, to recognize the need for a better understanding of the future of work.

The first image of a black hole, which captivated the world in 2019, has received a remarkable upgrade thanks to the application of artificial intelligence (AI). A research team utilized AI algorithms to enhance the initial image, resulting in a sharper depiction that showcases the black hole at the center of the M87 galaxy as darker and larger than before.

AI has been an integral part of astronomy for decades, with astronomers harnessing its power to study galaxies and explore cosmology. In 1990, researchers from the University of Arizona pioneered the use of neural networks, a form of AI, to analyze galaxy shapes. Since then, AI has permeated every aspect of astronomy, helping scientists navigate vast data sets and uncover new insights about the universe.

Throughout the history of astronomy, understanding the multitude of celestial objects has been a complex endeavor. The advancements in telescopes have led to a tremendous increase in the number of observable celestial entities, resulting in exponential growth in data volume. For instance, the forthcoming Vera Rubin Observatory in Chile is expected to generate an astonishing 0.5 exabytes of data over a decade, equivalent to around 50,000 times the information stored in the Library of Congress.

VeriSIM Life, a pioneering company in the field of artificial intelligence, has harnessed the power of digital twins and machine intelligence to revolutionize pharmaceutical testing. By creating digital replicas of various human body types and animal models, VeriSIM can predict the impact of pharmaceuticals on real-life subjects before even entering clinical trials, significantly reducing time, costs, and risks associated with drug development.

Founded in 2017 by Dr. Jo Varshney, a veterinarian with expertise in genomics and cancer biology, VeriSIM collaborates with pharmaceutical companies, biotech firms, and academic institutions to assess the efficacy and safety of medications using AI simulations instead of animal testing. This approach addresses the common challenge in drug development, as approximately 89% of drugs that pass animal testing fail in human trials.